Form 8-K · Current report
American Express 8-K, filed Jul 24, 2026
- Filed
- CIK
- 0000004962
- Accession no.
- 0000004962-26-000318
Summary
American Express reported its financial results for the second quarter of 2026 on July 24, 2026, furnishing an earnings release and additional financial information. Forward-looking statements in the disclosure cover management's 2026 guidance and long-term growth aspirations, subject to risks including credit performance, tariffs, interest rates, competition and regulation.
Key points
- American Express reported second-quarter 2026 financial results on July 24, 2026.
- The results were furnished along with an earnings release and additional information relating to the quarter's financial results.
- Forward-looking statements address management's 2026 guidance and long-term growth aspiration and are subject to risks and uncertainties.
- Among the cited risk factors are macroeconomic and geopolitical conditions, tariffs, credit performance, card fee and net interest income growth, rewards and marketing costs, and regulatory or litigation impacts.
Written by an AI model from the filing text. It can be incomplete or wrong; the filing on SEC.gov is the record.
Items reported
- 2.02Results of Operations and Financial Condition
- 7.01Regulation FD Disclosure
- 9.01Financial Statements and Exhibits
From the filing
Item 2.02 Results of Operations and Financial Condition and Item 7.01 Regulation FD Disclosure The following information is furnished under Item 2.02 – Results of Operations and Financial Condition and Item 7.01 – Regulation FD Disclosure: On July 24, 2026, American Express Company (the “Company”) reported financial results for the second quarter of 2026. A copy of the Company’s earnings release is attached to this report as Exhibit 99.1 and additional information relating to the Company’s financial results for the second quarter of 2026 is attached to this report as Exhibit 99.2. …
An excerpt of the text as filed with the SEC, cut for length.
Readster writes AI-generated summaries of public filings for research purposes only. Summaries can be incomplete or wrong — check the original filing on SEC.gov before relying on it. Nothing here is investment, legal or medical advice.